Therapy Areas: Cardiovascular
Heart Rhythm Society partners with Milestone Pharmaceuticals to offer new SVT patient resources
2 June 2026 - The Heart Rhythm Society (HRS) announced on Monday that it has formed a collaboration with Milestone Pharmaceuticals, an emerging commercial-stage biopharmaceutical company advancing inn...
Haisco receives US FDA approval for anaesthetic Cipepofol
...
Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026
1 June 2026 - Biopharmaceutical company Avacta Group PLC (AIM: AVCT) announced on Monday that it has presented updated clinical data from its Phase 1a/1b trial of AVA6000, its pre|CISION-enabled form ...
Circio and AaviGen partner to develop next-generation gene therapies for heart disease
27 May 2026 - Biotechnology companies Circio Holding ASA (OSE:CRNA) and AaviGen GmbH on Wednesday announced a research collaboration to develop circVec-enhanced AAV vectors engineered for targeted, lo...
Eli Lilly reports positive Phase 1b results for VERVE-102
26 May 2026 - US pharmaceutical company Eli Lilly and Company (NYSE:LLY) on Monday reported positive Phase 1b Heart-2 study results for VERVE-102, an investigational in vivo base editing medicine desi...
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
21 May 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) announced on Thursday that the US Food and Drug Administration (FDA) has accepted and granted Priority Rev...